AMGN compared with ALLO: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

ALLOAllogene Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

ALLOAllogene Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only ALLO 12

PFEPfizersupplier

NTRANaterasupplier

CLLSCellectissupplier

—Arbor Biotechnologiesunlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

supplier

8 more · ALLO chain ›

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

ALLOAllogene Therapeutics, Inc.

1.04▼−4.59%· post 1.07

ClosedNov 6 '26

Mkt cap$360.3MRevenue$5MQ2 FY26Revenue—

Compare

ClosedNov 6 '26

AMGNAmgen Inc

ALLOAllogene Therapeutics, Inc.

460.55▲+0.06%post 460.42

Price

1.04▼−4.59%post 1.07

$249.0B

Mkt cap

$360.3M

Q3 FY26$10.4B

Revenue

$5MQ2 FY26

FY25$36.8B

Revenue

—

AMGN460.55▲+0.06%vsALLO1.04▼−4.59%ClosedNov 6 '26